Friday, March 12, 2010
"Concise industry news from the US pharmaceutical industry..."
Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Blog
Where our team of editors discuss what they think about the current NGP US Issues.
Marie Shields
Editor NGP US
Editor NGP US
Sizing up the future
What role will individually tailored therapies play in the pharmaceutical industry’s new business models?01 Oct 2009
Focus Areas
Cover Stories
A New Generation of Vaccines
Novartis is making major investments to be able to offer novel influenza vaccines. Europe's second-largest pharmaceutical company, the fourth...
Brilliant BioPharma
Wyeth BioPharma is the fourth largest biotech company in the world, Cavan Redmond and Dr. Michael Kamarck talk to NGP’s Rebecca Goozee about...
The Fight Against TB
Robert Smith, President of the Eli Lilly and Company Foundation, and Dr. Gail Cassell, Vice President for Scientific Affairs and Distinguished...
Roundtables
-
The Future of Cell Biology
Kevin Daugherty, Director of Marketing for Greiner Bio-One, and Dr. David Kirk, Technical Director of MDS Pharma Services, sit down to discuss molecular and cell biology,...Read more -
Portfolio Management
Richard Sonnenblick, President of Enrich, John Howell, Founder and President of Portfolio Decisions and Dr. James Mattheson, Chariman and CFO of SmartOrg Inc. talk about...Read more
Vendor Perspectives
-
Forming Key Partnerships in the Producti...
The pharmaceutical industry is in the midst of unprecedented change. Scientific knowledge is expanding at such a rapid rate, that it is difficult for pharmaceutical...Read more -
Making Every Dollar Count for the Pharma...
Our industry faces unprecedented challenges to its long term sustainability with the loss of blockbuster products, thin pipelines, public scrutiny of marketing practices,...Read more
Industry Analysts
-
Bright Light, Long Tunnel
Kim Slocum, Founder of KDS Consulting gives his view on the future of the pharmaceutical industry.Read more -
Changing Business at Wyeth
Geno Germano, President – US and General Manager of Wyeth Pharmaceuticals, shares his insights around the drivers that have forced pharmaceutical companies to change their...Read more -
A Pragmatic Path to Enterprise Content Man...
Ken Lownie and Tim May, Glemser Technologies explain how and why pharma companies are seeking to combine and consolidate sets of applications.Read more -
The Right Approach to Risk
Christopher Carey of Bristol-Myers Squibb shares what’s driving adoption of enterprise risk management across the pharmaceutical industry.Read more
Executive Interviews
Vaccine Renaissance
With the very latest in x-ray crystallography, structure-based design and advances in cell-culture technology, it’s a renaissance period for vaccines, believes Dr. Gary Nabel, Director of the Vaccine Research Center within the National Institute f...
Read more
Delving Deeper into DNA
Dr. Patrice Milos, Vice President and Chief Scientific Officer of Helicos BioSciences explains her new role, the innovative new technology she works with and her vision for the future of DNA and RNA.
Read more
Striking the Benefit-Risk Balance
John Ferguson, VP of Pharmacovigilance at Novartis Vaccines and Diagnostics, examines today’s drug safety landscape.
Read more
Next Generation Healthcare Summit 2010
11th - 13th May
As healthcare costs continue to rise, health providers around the country feel a sharp sense of urgency in deploying information technology to lower costs, reduce medical errors, enhance outcomes, and spur efficiency in an industry known for legendary inefficiency.
Source: www.ngpharma.com© 2010 GDS Publishing Ltd. All rights reserved.